David Weinstock, MD, is a Professor at Harvard Medical School and a Medical Oncologist at the Dana-Farber Cancer Institute and the Brigham and Women’s Hospital in Boston, MA. Prof. Weinstock is an associate member in Cancer Biology of the Broad Institute of MIT and Harvard, and a Lavine Family Chair in Preventive Cancer Therapies at the Dana-Farber Cancer Institute. Prof. Weinstock is also a member of the Cancer Genetics & Epigenetics and Leukemia affiliation program and a member of the Center Scientific Council at the Dana-Farber/Harvard Cancer Center (DF/HCC).
Prof. Weinstock received his medical degree from the George Washington University School of Medicine (1997) and completed a residency in internal medicine at the New York Hospital/Cornell in New York City, NY. Following that, Prof. Weinstock received a fellowship to work on medical oncology and infectious diseases, specifically identifying mechanisms of oncogenic rearrangements, at the Memorial Sloan Kettering Cancer Center in New York City, NY. He is certified by the Infectious Diseases, Internal Medicine, and Medical Oncology Boards.
Speaking on lymphoma, myeloma and leukemia
Prof. Weinstock is particularly interested in the identification of therapeutic targets in lymphoid malignancies. His group is looking at DNA repair mechanisms in these diseases. In addition, this group is establishing patient-derived xenograft models of leukemias and lymphomas for pre-clinical research.